March 28, 2020

Tracheal Tube and Airway Products Market Is Expected To Reach US$ 5,646.2 Mn by 2027

The latest market report published by Credence Research, Inc. “Global Tracheal Tube and Airway Products Market – Growth, Future Prospects, Competitive Analysis, 2019- 2027,” The global market for tracheal tube and airway products was valued at US$ 3,150.1 million in 2018 and is expected to reach US$ 5,646.2 million by 2027, increasing to CAGR by 6.8 per cent from 2019 to 2027.

Market Insights 

There has been an increase in the number of adults smoking tobacco in recent years, which is the main precursor to any form of respiratory disease. Rising air pollution worldwide and a steady rise in trauma accidents requiring intubation have further accelerated the market growth of tracheal tubes and airway products.

Browse the full report at

Endotracheal tubes dominate the market for tracheal tubes and airway products. Significant increase in surgical procedures requiring anesthesia and flexibility in the delivery of medicines together in unconscious patients increases the demand for endotracheal tubes. Laryngeal masks gather tremendous response among surgeons as a viable option for mask anesthesia and in short surgical procedures that do not require endotracheal tubes.

Hospitals are leading the end-user segment of the market for tracheal tubes and airway products. The main aspects responsible for its magnificent growth are increasing public health awareness, resulting in a significant increase in the number of inpatient visits and the availability of an intensive care unit well equipped with airway products. Ambulatory surgical centers are gaining huge traction due to their ability to provide emergency medical intervention to patients suffering from pulmonary trauma in remote regions.

North America is leading the regional segment with a share of 35.1%. The major factors involved in its supreme market growth are rising prevalence of pulmonary disorders. According to Center for Disease Control and Prevention (CDC), research citing, chronic lower respiratory diseases are the 4th largest cause of death in the United States. Existence of pioneers such as Medline Industries, Inc., Medtronic, Plc., Teleflex Incorporated, Smiths Medical etc. further consolidates the market growth in the region. Europe is holding 30.6% market share on account of the supportive regulatory environment provided by the European Medical Agency (EMA) for the sale of tracheal tubes and airway products. Asia Pacific represents 16.8% market share and is keen to register imperative growth during the forecast period owing to the growing incidence of chronic pulmonary obstructive disease and significant rise in the number of smokers.

Credence Research is providing Free Sample Get it here:

Pharmaceutical companies pioneering in tracheal tube and airway products market are Altera A.S., BOMImed, Inc., Boston Medical Products, Inc., Flexicare Medical Ltd., Medtronic, Plc., Medline Industries, Inc., Penlon, Smiths Medical, Teleflex Incorporated and VBM Medizintechnik GmbH.

Key Market Movements:

  • Rising prevalence of chronic lower respiratory diseases throughout the globe
  • Significant rise in the number of surgeries performed with availability of tracheal tube and airway products in different configurations
  • Supportive regulatory environment provided by regulatory healthcare agencies worldwide

Report Scope by Segments

By Product Type

  • Breathing Circuits
  • Tracheostomy Tube
  • Endotracheal Tube
  • Laryngeal Mask
  • Others (Laryngoscopes, Oral/Nasal Airway Tubes)

By End User Type

  • Hospitals
  • Homecare Settings
  • Ambulatory Surgical Centers

By Geography Segment

  • North America (U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of the World (Middle East & Africa, Latin America)

Credence Research is providing Free Sample Get it here:

Leave a Reply

Your email address will not be published. Required fields are marked *